Top Story

Sanofi to acquire Bioverativ in multi-billion dollar deal

Deal represents equity value of approximately $11.6bn.

Read more

Company also recognised for renewable energy use....

Read more

Worldwide commercialisation responsibilities will be divided....

Read more

Half-brothers embark on 3000 mile row across Atlantic Ocean....

Read more

Approval based on data from randomised, open-label, Phase III OlympiAD trial....

Read more

Profiling to be added to HLI's premier assessment....

Read more

Approval based on results from the WINDWARD programme....

Read more

Clinical Entrepreneurs Programme supports NHS workers to learn from experts....

Read more

Investment in cemiplimab will be increased to $1.64 billion....

Read more

Almost half of survey respondents already using or experimenting with AI....

Read more

Company will reallocate funding away from neuroscience programme, affecting 300 jobs....

Read more